ArticleClinical oral investigations2026
Oral squamous cell carcinoma arising from oral epithelial dysplasia shows high postoperative recurrence despite favorable histopathology.
Article in Clinical oral investigations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesWe sought to determine whether oral epithelial dysplasia (OED)-derived oral squamous cell carcinoma (OSCC) represents a clinically and pathologically distinct subtype, given that a substantial subset of OSCC is known to arise from OED. MATERIALS AND
methodsThis retrospective study analyzed 335 patients with OSCC treated at our institution. OED-OSCC was defined as OSCC in patients with a documented history of biopsy-proven oral epithelial dysplasia, irrespective of the specific clinical lesion.
resultsOED-derived OSCC (OED-OSCC), defined by pathologically confirmed dysplasia rather than clinical presentation, comprised 195 (58.2%) patients in the cohort. Compared with non-OED-OSCC, it demonstrated less aggressive tumor-centric features including shallower DOI, lower PNI, earlier T stage, and fewer nodal metastases, yet paradoxically greater cumulative surgical burden with more patients undergoing multiple resections. Recurrence in OED-OSCC was significantly associated with margin dysplasia, which was more frequent than in non-OED-OSCC (74.00% vs. 48.97%). Moreover, recurrence rates increased with margin dysplasia severity (mild: 60%; moderate: 73.08%; severe: 100%), underscoring that field cancerization at the primary site may contribute to the distinct clinical behavior of OED-OSCC. The clinical value of dysplasia-free margins warrants prospective evaluation, as even mild dysplasia was associated with a 60% recurrence rate.
conclusionsOED-OSCC represents a pathologically anchored subgroup in which margin dysplasia severity was associated with high recurrence despite favorable tumor-centric features. These findings support prospective evaluation of mucosal margin status in risk stratification. CLINICAL RELEVANCE: By anchoring OSCC classification to histopathologically confirmed dysplasia, OED-OSCC identifies patients with a dysplastic background and elevated observed recurrence risk who may merit enhanced surveillance.
Indexed as
Identifiers
42803846What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.